U.S. market Open. Closes in 23 minutes

TDOC | Teladoc Health, Inc. Stock Fundamentals

(Stock Exchange: NYSE)
Analyzing fundamentals for TDOC we got that it has weak fundamentals where Valuation is considered to be slightly undervalued, Profitability is unacceptably poor, Growth is bad and Health is frighteningly weak.

Valuation (62%)

Company Industry
P/E Ratio (TTM) -1.55 20.53
PEG Ratio (TTM) 0.00 16.29
P/S Ratio (TTM) 0.60 7.08
P/B Ratio (TTM) 1.04 5.99
P/FCF Ratio (TTM) 8.02 17.03
Price to 5YR AVG Earnings Ratio -0.48 110.54
Price to 5YR AVG FCF Ratio 28.10 38.63

Profitability (25%)

Company Industry
ROA (TTM) -28.54% 1.55%
ROE (TTM) -47.82% 9.07%
Net Profit Margin (TTM) -38.54% 5.51%
ROIC 5YR AVG 30.73% 11.86%

Growth (42%)

4QTR AVG 3YR AVG 5YR AVG
EPS -257.10% -77.74% -626.74%
Revenue -0.38% 71.98% 48.49%
Net Income -261.14% -126.98% -673.62%
Cash Flow 207.15% 299.32% 196.09%

Health (30%)

Company Industry
Current Ratio (TTM) 1.62 2.47
Quick Ratio (TTM) 1.59 2.29
D/E Ratio (TTM) 1.03 0.72
Interest Coverage (TTM) -8.86 6.71
Piotroski F-Score 5 5
Altman Z-Score N/A 7.53
LTL to 5YR AVG FCF 28.27 2.07
Shares Outstanding Growth 5YR AVG 22.66% 4.76%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙